Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Experion Biotechnologies is a Canadian cannabis company focused on the cultivation and processing of cannabis products for medical and adult-use markets. The company operated a licensed production facility in Mission, British Columbia, and was described by its parent organizations as a Health Canada licensed cultivator and processor of cannabis. Experion functioned as the operating subsidiary behind the broader Experion Holdings/Citizen Stash platform, supplying premium flower and related cannabis products. In November 2021, its parent Citizen Stash Cannabis was acquired by The Valens Company, making Experion an acquired operating business within that transaction. The company appears to have been primarily commercial rather than drug-development-stage biotech, with no conventional therapeutic pipeline publicly disclosed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Experion Biotechnologies.